Cerebrospinal fluid markers of disturbed brain cell metabolism.
Reversibly and irreversibly disturbed brain cell metabolism may be monitored in an indirect way by the analyses of enzymes in the CSF according to the hypothesis of cell swelling induced by energy shortage. Adenylate kinase fulfils the criteria for an ideal CSF marker with the exception that it is not organspecific, which necessitates precautions to avoid influence of AK in erythrocytes and serum. When taking such limitating factors into account, AK determinations may be diagnostically useful in combination with radiological and clinical observations. Besides, it is possible that a combination of AK analyses and clinical signs are useful in the prognostication in individual patients suffering from global cerebral ischemia and cerebral infarction.
D000263:Adenylate Kinase / Q000134:cerebrospinal fluid; D001921:Brain / Q000378:metabolism*; D001927:Brain Diseases / Q000134:cerebrospinal fluid* / Q000175:diagnosis; D002545:Brain Ischemia / Q000134:cerebrospinal fluid; D002543:Cerebral Hemorrhage / Q000134:cerebrospinal fluid; D002555:Cerebrospinal Fluid / Q000502:physiology*; D003704:Dementia / Q000134:cerebrospinal fluid; D005978:Glutathione / Q000134:cerebrospinal fluid; D006801:Humans; D007003:Hypoglycemia / Q000134:cerebrospinal fluid; D000860:Hypoxia / Q000134:cerebrospinal fluid; D008581:Meningitis / Q000134:cerebrospinal fluid
D000263:Adenylate Kinase; D005978:Glutathione